S. Jones, M. Smith, and J. Rossaak, MBBCh, FRACS, PhD, “Targin®: An effective opiate analgesia with minimal gastrointestinal side effects—An observational study”, J of Opioid Management, vol. 18, no. 3, pp. 281–286, May 2022.